IQ3CORP LIMITED - Announcements

0.00%

12.0¢

Currently unlisted.

iQ3Corp Ltd is an Australia-based company that is engaged in the provision of capital... iQ3Corp Ltd is an Australia-based company that is engaged in the provision of capital raising and corporate advisory services to listed and unlisted companies in the life science industry. The Company's segments include consulting services and shared services. consulting services segment includes capital raising and corporate advisory fees. shared services segment includes office and shared services revenue. It provides advices to life science companies on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance to corporations, partnerships, institutions, governments, and individuals. It offers various services, such as initial public offerings, listings, private equity, merger and acquisitions, sell-side advisory, buy-side advisory, structured finance and N.S.X. nominated advisor. The Company has six wholly owned subsidiaries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

IQ3	iQ3Corp Ltd Seeks Voluntary Administration to Restructure	PRICE SENSITIVE	11/03/22	249.47KB	Share
IQ3	Suspension from Official Quotation	PRICE SENSITIVE	01/03/22	71.68KB	Share
IQ3	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/01/22	1.43MB	Share
IQ3	Addendum to 2021 Financial Report	PRICE SENSITIVE	15/12/21	370KB	Share
IQ3	Gold Technology for Immune Response Cancer Therapy Licensed	PRICE SENSITIVE	05/11/21	223.64KB	Share
IQ3	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	26/10/21	1.44MB	Share
IQ3	Full Year Statutory Accounts	PRICE SENSITIVE	27/08/21	942.55KB	Share
IQ3	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/21	566.44KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/21	564.68KB	Share
IQ3	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/21	621.09KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/21	712.89KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/20	424.17KB	Share
IQ3	Appendix 4E and 2020 Annual Report	PRICE SENSITIVE	28/08/20	661.92KB	Share
IQ3	Quarterly Cashflow Report	PRICE SENSITIVE	29/07/20	562.69KB	Share
IQ3	Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	30/04/20	559.51KB	Share
IQ3	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/20	399.58KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/20	306.82KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/19	373.86KB	Share
IQ3	Response to ASX Aware Query	PRICE SENSITIVE	23/09/19	504.46KB	Share
IQ3	IQ3 acquires interest in a new anticancer drug platform	PRICE SENSITIVE	17/09/19	181.26KB	Share
IQ3	Full Year Statutory Accounts 30 June 2019	PRICE SENSITIVE	30/08/19	1.09MB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/19	348.58KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/19	1.05MB	Share
IQ3	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/19	1.86MB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/19	450.08KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/18	428.98KB	Share
IQ3	Preliminary Final Report	PRICE SENSITIVE	31/08/18	1.6MB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/18	455.12KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/18	1.31MB	Share
IQ3	Half Yearly Report and Accounts December 2017	PRICE SENSITIVE	27/02/18	710.08KB	Share
IQ3	Quarterly Cashflow Report	PRICE SENSITIVE	31/01/18	1.09MB	Share
IQ3	Appendix 4C	PRICE SENSITIVE	31/10/17	522.85KB	Share
IQ3	Appendix 4E - Preliminary Financial Result	PRICE SENSITIVE	31/08/17	713.09KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/17	373.6KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/17	306.83KB	Share
IQ3	Half Year Accounts	PRICE SENSITIVE	28/02/17	796.69KB	Share
IQ3	Response to ASX Appendix 4C Query	PRICE SENSITIVE	01/02/17	564.04KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/17	501.16KB	Share
IQ3	Appendix 4C - quarterly-IQ3.AX	PRICE SENSITIVE	28/10/16	1MB	Share
IQ3	2016 Annual Report to shareholders-IQ3.AX	PRICE SENSITIVE	31/08/16	1.24MB	Share
IQ3	Appendix 4C - quarterly-IQ3.AX	PRICE SENSITIVE	29/07/16	108.22KB	Share
IQ3	Appendix 4C - quarterly-IQ3.AX	PRICE SENSITIVE	29/04/16	113.67KB	Share
IQ3	Appointment to Advise Investment Consortium-IQ3.AX	PRICE SENSITIVE	05/04/16	277.01KB	Share
IQ3	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/16	1.54MB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	188.1KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/15	95.3KB	Share
IQ3	App 4E / Full Year Statutory Accounts	PRICE SENSITIVE	31/08/15	1.07MB	Share
IQ3	iQ3Corp Ltd announces investment banking arm	PRICE SENSITIVE	19/08/15	214.36KB	Share
IQ3	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/15	117.51KB	Share
IQ3	Appointment to Capital Raise $100m for Fund	PRICE SENSITIVE	02/06/15	178.5KB	Share
IQ3	Appointment as Lead Manager - iQnovate Ltd Private Placement	PRICE SENSITIVE	01/06/15	190.61KB	Share
IQ3	Appointment of CEO	PRICE SENSITIVE	21/05/15	262.86KB	Share
IQ3	Admission to Official List	PRICE SENSITIVE	14/05/15	25.29KB	Share

IQ3 iQ3Corp Ltd Seeks Voluntary Administration to Restructure
11/03/22	PRICE SENSITIVE	249.47KB	Share
IQ3 Suspension from Official Quotation
01/03/22	PRICE SENSITIVE	71.68KB	Share
IQ3 Quarterly Activities/Appendix 4C Cash Flow Report
28/01/22	PRICE SENSITIVE	1.43MB	Share
IQ3 Addendum to 2021 Financial Report
15/12/21	PRICE SENSITIVE	370KB	Share
IQ3 Gold Technology for Immune Response Cancer Therapy Licensed
05/11/21	PRICE SENSITIVE	223.64KB	Share
IQ3 Quarterly Activities/Appendix 4C Cash Flow Report
26/10/21	PRICE SENSITIVE	1.44MB	Share
IQ3 Full Year Statutory Accounts
27/08/21	PRICE SENSITIVE	942.55KB	Share
IQ3 Quarterly Activities/Appendix 4C Cash Flow Report
28/07/21	PRICE SENSITIVE	566.44KB	Share
IQ3 Appendix 4C - quarterly
28/04/21	PRICE SENSITIVE	564.68KB	Share
IQ3 Half Yearly Report and Accounts
24/02/21	PRICE SENSITIVE	621.09KB	Share
IQ3 Appendix 4C - quarterly
27/01/21	PRICE SENSITIVE	712.89KB	Share
IQ3 Appendix 4C - quarterly
30/10/20	PRICE SENSITIVE	424.17KB	Share
IQ3 Appendix 4E and 2020 Annual Report
28/08/20	PRICE SENSITIVE	661.92KB	Share
IQ3 Quarterly Cashflow Report
29/07/20	PRICE SENSITIVE	562.69KB	Share
IQ3 Quarterly Activities Report & Appendix 4C
30/04/20	PRICE SENSITIVE	559.51KB	Share
IQ3 Half Yearly Report and Accounts
28/02/20	PRICE SENSITIVE	399.58KB	Share
IQ3 Appendix 4C - quarterly
31/01/20	PRICE SENSITIVE	306.82KB	Share
IQ3 Appendix 4C - quarterly
30/10/19	PRICE SENSITIVE	373.86KB	Share
IQ3 Response to ASX Aware Query
23/09/19	PRICE SENSITIVE	504.46KB	Share
IQ3 IQ3 acquires interest in a new anticancer drug platform
17/09/19	PRICE SENSITIVE	181.26KB	Share
IQ3 Full Year Statutory Accounts 30 June 2019
30/08/19	PRICE SENSITIVE	1.09MB	Share
IQ3 Appendix 4C - quarterly
31/07/19	PRICE SENSITIVE	348.58KB	Share
IQ3 Appendix 4C - quarterly
30/04/19	PRICE SENSITIVE	1.05MB	Share
IQ3 Half Yearly Report and Accounts
27/02/19	PRICE SENSITIVE	1.86MB	Share
IQ3 Appendix 4C - quarterly
31/01/19	PRICE SENSITIVE	450.08KB	Share
IQ3 Appendix 4C - quarterly
31/10/18	PRICE SENSITIVE	428.98KB	Share
IQ3 Preliminary Final Report
31/08/18	PRICE SENSITIVE	1.6MB	Share
IQ3 Appendix 4C - quarterly
31/07/18	PRICE SENSITIVE	455.12KB	Share
IQ3 Appendix 4C - quarterly
30/04/18	PRICE SENSITIVE	1.31MB	Share
IQ3 Half Yearly Report and Accounts December 2017
27/02/18	PRICE SENSITIVE	710.08KB	Share
IQ3 Quarterly Cashflow Report
31/01/18	PRICE SENSITIVE	1.09MB	Share
IQ3 Appendix 4C
31/10/17	PRICE SENSITIVE	522.85KB	Share
IQ3 Appendix 4E - Preliminary Financial Result
31/08/17	PRICE SENSITIVE	713.09KB	Share
IQ3 Appendix 4C - quarterly
27/07/17	PRICE SENSITIVE	373.6KB	Share
IQ3 Appendix 4C - quarterly
28/04/17	PRICE SENSITIVE	306.83KB	Share
IQ3 Half Year Accounts
28/02/17	PRICE SENSITIVE	796.69KB	Share
IQ3 Response to ASX Appendix 4C Query
01/02/17	PRICE SENSITIVE	564.04KB	Share
IQ3 Appendix 4C - quarterly
27/01/17	PRICE SENSITIVE	501.16KB	Share
IQ3 Appendix 4C - quarterly-IQ3.AX
28/10/16	PRICE SENSITIVE	1MB	Share
IQ3 2016 Annual Report to shareholders-IQ3.AX
31/08/16	PRICE SENSITIVE	1.24MB	Share
IQ3 Appendix 4C - quarterly-IQ3.AX
29/07/16	PRICE SENSITIVE	108.22KB	Share
IQ3 Appendix 4C - quarterly-IQ3.AX
29/04/16	PRICE SENSITIVE	113.67KB	Share
IQ3 Appointment to Advise Investment Consortium-IQ3.AX
05/04/16	PRICE SENSITIVE	277.01KB	Share
IQ3 Half Yearly Report and Accounts
29/02/16	PRICE SENSITIVE	1.54MB	Share
IQ3 Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	188.1KB	Share
IQ3 Appendix 4C - quarterly
29/10/15	PRICE SENSITIVE	95.3KB	Share
IQ3 App 4E / Full Year Statutory Accounts
31/08/15	PRICE SENSITIVE	1.07MB	Share
IQ3 iQ3Corp Ltd announces investment banking arm
19/08/15	PRICE SENSITIVE	214.36KB	Share
IQ3 Appendix 4C - quarterly
30/07/15	PRICE SENSITIVE	117.51KB	Share
IQ3 Appointment to Capital Raise $100m for Fund
02/06/15	PRICE SENSITIVE	178.5KB	Share
IQ3 Appointment as Lead Manager - iQnovate Ltd Private Placement
01/06/15	PRICE SENSITIVE	190.61KB	Share
IQ3 Appointment of CEO
21/05/15	PRICE SENSITIVE	262.86KB	Share
IQ3 Admission to Official List
14/05/15	PRICE SENSITIVE	25.29KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

IQ3CORP LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available